Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Epitinib succinate (HMPL-813 succinate) is an orally active and brain penetration EGFR tyrosine kinase inhibitor and can be used in studies about cancer.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 27,000 | |||
2 mg | 在庫あり | ¥ 39,000 | |||
5 mg | 在庫あり | ¥ 66,500 | |||
10 mg | 在庫あり | ¥ 110,000 | |||
25 mg | 在庫あり | ¥ 181,000 | |||
50 mg | 在庫あり | ¥ 248,000 | |||
100 mg | 在庫あり | ¥ 340,000 | |||
500 mg | 在庫あり | ¥ 682,000 |
説明 | Epitinib succinate (HMPL-813 succinate) is an orally active and brain penetration EGFR tyrosine kinase inhibitor and can be used in studies about cancer. |
別名 | HMPL-813 succinate |
分子量 | 548.59 |
分子式 | C28H32N6O6 |
CAS No. | 2252334-12-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 11.7 mg/mL (21.3 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Epitinib succinate 2252334-12-4 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR HMPL-813 succinate HMPL 813 Succinate HMPL813 Succinate HMPL-813 Succinate Epitinib Succinate Inhibitor inhibitor inhibit